Clinical Pharmacy Congress 2024
Clinical Pharmacy Congress 2024 17th May 2024

We recently exhibited at Clinical Pharmacy Congress at ExCel London. We were there to showcase how we innovate the world of pharma supply and distribution with:

 

Hospital Distribution

Imported Unlicensed Medicines

 Hospital Over-labelling

 Healthcare Third Party Logistics

 

It was a very productive show and we had some great conversations with clients old and new! There were many compliments on our stand, which we are very grateful to Quadrant (link) for building to such a high standard.

 

Thanks to our colleagues who made the show a success!

 

If you would like to know more about our services please email info@mawdsleys.co.uk

Other latest news
https://www.mawdsleys.co.uk/news/mawdsleys-helps-client-deliver-major-project-to-large-chain-of-opticians/ thumbnail image Mawdsleys helps client deliver major project to large chain of opticians

We’re delighted with the feedback that our over-labelling and MPW (Mawdsleys Pre Wholesale) teams received from Thea Pharmaceuticals when they delivered on a major project for a large chain of opticians, despite the goal posts shifting a few times.   Thea, a client of Mawdsleys 3PL division, MPW, needed Mawdsleys…

Read more
https://www.mawdsleys.co.uk/news/mawdsleys-and-meabco-launch-a-named-patient-supply-program-for-bp-c1/ thumbnail image Mawdsleys and Meabco launch a Named Patient Supply program for BP-C1

Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1 on an unlicensed basis for the treatment of metastatic breast cancer and incurable pancreatic cancer.   BP-C1 is a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II)…

Read more
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.